0.000132749236691957 0.000132749236691957 0.000265498473383914 -0.000929244656843133 -0.00159299084030254 -0.00132749236691881 -0.00159299084030254 -0.00305323244391331
Thanks for submitting the form.
Stockreport

Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth [Yahoo! Finance]

Hologic, Inc. (HOLX)  More Company Research Source: Yahoo! Finance
Last hologic, inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.hologic.com
Moreover, Hologic's Molecular Diagnostics business is likely to register strong growth driven by a combination of newer assays like BV and CV/TV. We anticipate HOLX's second-quarter fiscal 2024 performance, scheduled for release on May 2 after the closing bell, to reflect these aspects. Click here to know how the company's overall fiscal second-quarter performance is expected to be. GYN Surgical Hologic's GYN Surgical is expected to have registered vital contributions from MyoSure and the related fluid system. The company is likely to have benefited from the strong performance of its latest NovaSure iteration, the NovaSure V5, in the fiscal second quarter. Further, we are also upbeat about the company's laparoscopic portfolio, which continues to build momentum and is growing into a larger driver for the division. Through Acessa and Bolder acquisitions, the company integrated Acessa's procedure and Bolder's advanced vessel sealing portfolio into its product line. We believe [Read more]

IMPACT SNAPSHOT EVENT TIME: HOLX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Stockreport

Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth [Yahoo! Finance]

Hologic, Inc.  (HOLX) 
Last hologic, inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.hologic.com
Moreover, Hologic's Molecular Diagnostics business is likely to register strong growth driven by a combination of newer assays like BV and CV/TV. We anticipate HOLX's second-quarter fiscal 2024 performance, scheduled for release on May 2 after the closing bell, to reflect these aspects. Click here to know how the company's overall fiscal second-quarter performance is expected to be. GYN Surgical Hologic's GYN Surgical is expected to have registered vital contributions from MyoSure and the related fluid system. The company is likely to have benefited from the strong performance of its latest NovaSure iteration, the NovaSure V5, in the fiscal second quarter. Further, we are also upbeat about the company's laparoscopic portfolio, which continues to build momentum and is growing into a larger driver for the division. Through Acessa and Bolder acquisitions, the company integrated Acessa's procedure and Bolder's advanced vessel sealing portfolio into its product line. We believe [Read more]

IMPACT SNAPSHOT
EVENT TIME:
HOLX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS